Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Phio Pharmaceuticals Corp (PHIO)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 5,780,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3302 - $0.3302
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year    
 
Company Profile   Phio Pharmaceuticals is developing therapeutics that use its INTASYL™ technology to target both tumor and immune cells by regulating genes to strengthen a patient's immune system while weakening tumor defense mechanisms. Co.'s INTASYL-based therapeutics are used to: strengthen immune cells, for example those administered as part of adoptive cell therapy (ACT), and directly modify cells in the tumor microenvironment to weaken a tumor's defense. Co.'s lead product candidate being developed by Co. in ACT is PH-762. Co.'s second product candidate in development for use in ACT is PH-894. Co.'s INTASYL compound PH-804 is also being developed for use in ACT.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 2,500 6,500 22,216
Total Buy Value $0 $2,275 $14,195 $22,362
Total People Bought 0 1 2 2
Total Buy Transactions 0 1 4 12
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 238
  Page 7 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2014-02-20 4 D $4.70 $5,640 D/D (1,200) 1,294,377     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-31 4 B $3.19 $2,552 D/D 800 21,100 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-30 4 B $3.09 $618 D/D 200 20,300 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-23 4 B $3.34 $3,340 D/D 1,000 20,100 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-22 4 B $3.43 $1,029 D/D 300 19,100 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-18 4 B $3.29 $1,367 D/D 400 18,800 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-16 4 B $3.53 $353 D/D 100 18,400 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-15 4 B $3.51 $351 D/D 100 18,300 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-14 4 B $3.54 $354 D/D 100 18,200 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-09 4 B $3.15 $3,150 D/D 1,000 18,100 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-04 4 B $3.49 $698 D/D 200 17,100 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-10-03 4 B $3.51 $351 D/D 100 16,900 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-30 4 B $3.42 $1,026 D/D 300 16,800 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-26 4 B $3.50 $1,050 D/D 300 16,500 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-24 4 B $3.49 $349 D/D 100 16,200 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-23 4 B $3.49 $607 D/D 174 16,100 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-20 4 B $3.52 $1,148 D/D 326 15,926 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-18 4 B $3.48 $698 D/D 200 15,600 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-17 4 B $3.55 $710 D/D 200 15,400 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-13 4 B $3.55 $715 D/D 200 15,200 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-11 4 B $3.55 $533 D/D 150 15,000 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-09-10 4 B $3.58 $1,267 D/D 350 14,850 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-08-30 4 B $3.35 $1,008 D/D 300 14,500 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-08-29 4 B $3.40 $1,390 D/D 400 14,200 2.73     -
   Lockshin Curtis Director   –       •      –    2013-08-29 4 B $3.70 $3,700 D/D 1,000 1,000 2.31     -
  238 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us